Speakers
The 2023 List of Faculty – Work in progress
James J Carroll
Jame J. Carroll has 10 + years of early Life Science Company fundraising and investment experience as Founder and General Partner at Boston Life Science Investments and as Managing Director of Wharton Alumni Angels for Life Science Investments. At Boston Life Science Investments he advises and connects emerging innovators in life science-related technologies with early-stage capital critical to initial startup for growth and eventual successful deal exits
Yvette Cleland
Yvette Cleland is CEO of CPL Life Sciences, a global staffing firm specializing in exceptional talent within Biopharma. Having come from the pharmaceutical sector herself she leads with an innate understanding of talent needs, shortages & addressing the dilemma’s. Yvette has been recognized since 2018 by Staffing Industry Analysts (SIA) as one of the top 50 most powerful women in staffing globally. In recent years her work was included in a UK Parliamentary Review
Vanessa Elharrar
Vanessa Elharrar, M.D., MPH, is Vice President Vaccines Strategy Lead within PPD Biotech. She has been focused exclusively on COVID-19 clinical development since the beginning of the pandemic. She has 14+ years experience in infectious disease clinical research and NIH leadership.
Jessica Foley
Jessica Foley, RAC: Regulatory Affairs Certified, Principal, Gaia Regulatory Sciences LLC. She is a regulatory expert with 17 years of experience in rare and common disease indications, including pulmonary, immunology, neurology, inflammation, and oncology. She provides strategic advice, submissions support, and due diligence services for small molecule, biologic, and cell and gene therapy development programs and has directed the preparation of global health authority interactions.Â
Marc B. Garnick
Marc B. Garnick, M.D., is the Gorman Brothers Professor of Medicine at Harvard Medical School (HMS) and the Beth Israel Deaconess Medical Center, where he also directs the Hospital’s role as a tertiary cancer center for 7 affiliated community cancer centers. He has just completed a 10 year tenure as a special governmental advisory member of multiple FDA panels and advisory committees.Â
Shahin Gharakhanian
Shahin Gharakhanian, MD, DPH, specializes in Drug & Vaccine Clinical Development & Medical Affairs, based in the Cambridge Innovation Center. He has extensive track record in Pharmaceutical Medicine, Executive Leadership & Management. Dr Gharakhanian has led or managed projects for 12 different companies, ten brands in different geographies (Asia, Europe, USA) including four NDA/MAA/launches, most recently a 2011 “blockbuster” in the US.
Silvia Helou
Silvia Helou, MD, Executive Consultant & Founder, HConsulting LLC. Silvia has extensive drug development experience in major therapeutic areas including anti-infectives, dermatology, oncology/hematology, and immunology/biologics. She previously held various senior positions at Novartis, Schering-Plough and Scynexis in clinical development.
Frederic Jallat
Dr. FrĂ©dĂ©ric Jallat is currently Professor, Academic Director of the Advanced Master in Biopharmaceutical Management (MsM – Paris & London), Associate Research Fellow at ESCP Business School, and an affiliated Professor at Sciences Po. Paris. He is currently working, as Co-Academic Director of the Advanced Management Program in Life Sciences and Health (APiL), on the development of a major initiative for entrepreneurship and innovation together with Institut Pasteur.
CĂ©cile Le Camus
Cecile Le Camus, MD, Global Head of Hemophilia for RBD (Rare Blood Disorders), Medical Affairs Group, Sanofi, Cambridge MA, USA. Formerly she was head of the US Medical Affairs at Vertex Pharmaceuticals, Boston MA.
Brian Malkin
Brian Malkin, Partner, McDermott Will & Emery, counsels pharmaceutical and biologic clients on Food and Drug Administration (FDA) regulatory matters and intellectual property (IP) law, with an emphasis on patent litigation.Â
Mac Martirossian
Mac Martirossian, CPA, Managing Director, MThree Advisory, Atlanta GA. Mac is a senior level General Management executive with a successful history of maximizing organizational effectiveness, profit and cash flow, both domestically and internationally.Â
Yacine Salhi
Consul General of France in Boston. Prior to his appointment, he served as Technical Advisor for European Affairs at Matignon, in the offices of Édouard PHILIPPE, Jean CASTEX and Élisabeth BORNE. He previously served as spokesperson, head of the press office of the French Embassy in Italy (2016-2020) and at the French Permanent Representation to the European Union in Brussels (2012-2016). In Paris, he worked at the Quai d’Orsay at the Directorate-General for Globalization (2009-2012) and at the Ministry of Economy and Finance (2003-2009). Mustafa SOYKURT is Public Law graduate.Â
Mustafa Soykurt
Consul General of France in Boston. Prior to his appointment, he served as Technical Advisor for European Affairs at Matignon, in the offices of Édouard PHILIPPE, Jean CASTEX and Élisabeth BORNE. He previously served as spokesperson, head of the press office of the French Embassy in Italy (2016-2020) and at the French Permanent Representation to the European Union in Brussels (2012-2016). In Paris, he worked at the Quai d’Orsay at the Directorate-General for Globalization (2009-2012) and at the Ministry of Economy and Finance (2003-2009). Mustafa SOYKURT is Public Law graduate.Â
